Business Context and Reporting Period
Company: Gladstone Capital Corporation (GLAD)
Filing Type: Form 10-K (Annual Report)
Period Ended: September 30, 2013
Business Overview: Gladstone Capital is an externally managed, closed-end, non-diversified management investment company operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company invests primarily in debt and equity securities of established private U.S. businesses. Its strategy targets a portfolio allocation of approximately 95% debt and 5% equity, focusing on senior, senior subordinated, and junior subordinated debt, as well as preferred and common equity.
Key Financial Metrics
| Metric | 2013 (in thousands) | 2012 (in thousands) |
|---|---|---|
| Total Investment Income | $36,154 | $40,322 |
| Net Investment Income | $18,386 | $19,044 |
| Net Increase in Net Assets from Operations | $32,219 | $(8,008) |
| Total Assets | $295,091 | $293,402 |
| Net Assets | $205,992 | $188,564 |
| Net Asset Value (NAV) per Share | $9.81 | $8.98 |
| Portfolio Fair Value | $256,878 | $273,960 |
| Portfolio Cost Basis | $332,266 | $365,021 |
| Borrowings (Credit Facility) | $46,900 | $58,800 |
| Term Preferred Stock | $38,497 | $38,497 |
| Asset Coverage Ratio | 341% | 296% |
| Weighted Average Yield on Investments | 11.63% | 11.25% |
Material Changes vs. Prior Period
- Operational Performance: The company reported a net increase in net assets of $32.2 million for 2013, a significant improvement from a net decrease of $8.0 million in 2012. This turnaround was driven primarily by a net unrealized appreciation of $15.7 million in 2013, compared to net unrealized depreciation of $11.2 million in 2012.
- Portfolio Contraction: The portfolio fair value decreased by approximately $17.1 million year-over-year. This was due to significant unscheduled principal repayments of $103.1 million (including 14 early payoffs totaling $79.6 million) and sales of investments, which were only partially offset by $80.4 million in new investments.
- Non-Accrual Status: The number of portfolio companies on non-accrual status improved from six in 2012 to two in 2013. The aggregate debt cost basis of non-accrual loans decreased from $61.1 million (17.3% of debt cost) to $39.5 million (12.6% of debt cost).
- Expense Reduction: Total expenses net of credits decreased by 16.5% to $17.8 million, primarily due to reduced interest expense on borrowings and lower incentive fees.
Guidance, Outlook, and Risks
Management Commentary: Management views the economic environment as a "protracted economic recovery" but remains cautious due to lingering recessionary effects and U.S. fiscal uncertainty. The company successfully extended its Credit Facility maturity to January 2016 and removed the LIBOR floor on advances. The company continues to focus on building a pipeline of investments that provide appropriate returns given the risks.
Key Risks and Contingencies:
- Liquidity and Financing: The company relies on a $137 million revolving credit facility. Failure to comply with covenants (e.g., asset coverage, minimum net worth) could accelerate repayment obligations. The facility matures in 2016, and renewal is not guaranteed.
- Valuation Uncertainty: All investments are valued using Level 3 inputs (unobservable data). Fair value estimates may differ significantly from values realized upon sale, particularly for illiquid private securities.
- Concentration Risk: The five largest investments represented 37.4% of the total portfolio at fair value. The portfolio is also concentrated in specific industries, with Healthcare/Education (17.7%) and Electronics (13.1%) being the largest sectors.
- Regulatory Constraints: As a BDC, the company is subject to asset coverage requirements (minimum 200%) which limit leverage and the ability to pay distributions if asset values decline.
- Return of Capital: Distributions to common stockholders exceeded earnings and profits in 2013, resulting in a partial return of capital of approximately $1.3 million.
Investor Verification Checklist
- Verify Non-Accrual Trends: Confirm the status of the two remaining non-accrual loans and the likelihood of recovery or further write-downs.
- Assess Credit Facility Renewal: Monitor the company's ability to renew or refinance its $137 million credit facility maturing in January 2016.
- Review Valuation Methodologies: Scrutinize the Level 3 valuation inputs (EBITDA multiples, discount rates) used for the $256.9 million portfolio, given the lack of active markets.
- Check Distribution Coverage: Verify if future distributions will continue to be fully covered by net investment income or if further returns of capital are anticipated.
- Monitor Portfolio Concentration: Track the performance of the top five holdings, which comprise over one-third of the portfolio's fair value.